Cytochrome P450 17A1 Inhibitor class drugs

6 results

  • abiraterone

    (Abiraterone acetate)
    CivicaScript, LLC
    Abiraterone acetate tablets are indicated in combination with prednisone for the treatment of metastatic castration-resistant prostate cancer (CRPC) and metastatic high-risk castration-sensitive prostate cancer (CSPC).
    Medication Details
    Drug Interactions

  • abiraterone acetate

    (abiraterone acetate)
    Novugen Pharma (USA) LLC
    Abiraterone acetate tablets are indicated, in combination with prednisone, for the treatment of metastatic castration-resistant prostate cancer (CRPC) and metastatic high-risk castration-sensitive prostate cancer (CSPC).
    Medication Details
    Drug Interactions

  • akeega

    (NIRAPARIB TOSYLATE MONOHYDRATE and ABIRATERONE ACETATE)
    Janssen Biotech, Inc.
    AKEEGA, in combination with prednisone, is indicated for adult patients with deleterious or suspected deleterious BRCA-mutated metastatic castration-resistant prostate cancer (mCRPC). Treatment selection should be based on an FDA-approved test for AKEEGA.
    Medication Details
    Drug Interactions

  • zytiga

    (abiraterone acetate)
    Janssen Biotech, Inc.
    ZYTIGA is indicated for the treatment of metastatic castration-resistant prostate cancer (CRPC) and metastatic high-risk castration-sensitive prostate cancer (CSPC) when used in combination with prednisone.
    Medication Details
    Drug Interactions